Conflict of interest: VL has received a travel grant from Basilea Pharmaceutica. TH has received travel grants from Basilea Pharmaceutica and Almirall. TR has acted as a principal investigator, speaker and consultant for Basilea Pharmaceutica. SM has acted as speaker, subinvestigator and consultant for, and received travel grants and author honoraria from Basilea Pharmaceutica, and has also received travel grants and acted as a speaker for Almirall.
Clinical dermatology ● Concise report
Treatment of Darier disease with oral alitretinoin
Article first published online: 18 JUN 2013
© 2013 British Association of Dermatologists
Clinical and Experimental Dermatology
Volume 38, Issue 5, pages 523–525, July 2013
How to Cite
Letulé, V., Herzinger, T., Ruzicka, T. and Molin, S. (2013), Treatment of Darier disease with oral alitretinoin. Clinical and Experimental Dermatology, 38: 523–525. doi: 10.1111/ced.12078
The first two authors contributed equally to this paper.
- Issue published online: 18 JUN 2013
- Article first published online: 18 JUN 2013
- Manuscript Accepted: 5 OCT 2012